Plasma Derived Medicine Market Size, Share, Growth, and Industry Analysis, By Type (Albumin,Immune Globulin,Coagulation Factor,Others), By Application (Bleeding Wound,Immunodeficiency,HBV,Tetanus,Rabies,Hemophilia,Others), Regional Insights and Forecast to 2035

1 Market Overview
1.1 Plasma Derived Medicine Product Introduction
1.2 Global Plasma Derived Medicine Market Size Forecast
1.2.1 Global Plasma Derived Medicine Sales Value (2019-2030)
1.2.2 Global Plasma Derived Medicine Sales Volume (2019-2030)
1.2.3 Global Plasma Derived Medicine Sales Price (2019-2030)
1.3 Plasma Derived Medicine Market Trends & Drivers
1.3.1 Plasma Derived Medicine Industry Trends
1.3.2 Plasma Derived Medicine Market Drivers & Opportunity
1.3.3 Plasma Derived Medicine Market Challenges
1.3.4 Plasma Derived Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasma Derived Medicine Players Revenue Ranking (2023)
2.2 Global Plasma Derived Medicine Revenue by Company (2019-2024)
2.3 Global Plasma Derived Medicine Players Sales Volume Ranking (2023)
2.4 Global Plasma Derived Medicine Sales Volume by Company Players (2019-2024)
2.5 Global Plasma Derived Medicine Average Price by Company (2019-2024)
2.6 Key Manufacturers Plasma Derived Medicine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Plasma Derived Medicine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Plasma Derived Medicine
2.9 Plasma Derived Medicine Market Competitive Analysis
2.9.1 Plasma Derived Medicine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Plasma Derived Medicine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Albumin
3.1.2 Immune Globulin
3.1.3 Coagulation Factor
3.1.4 Others
3.2 Global Plasma Derived Medicine Sales Value by Type
3.2.1 Global Plasma Derived Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Plasma Derived Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Plasma Derived Medicine Sales Value, by Type (%) (2019-2030)
3.3 Global Plasma Derived Medicine Sales Volume by Type
3.3.1 Global Plasma Derived Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Plasma Derived Medicine Sales Volume, by Type (2019-2030)
3.3.3 Global Plasma Derived Medicine Sales Volume, by Type (%) (2019-2030)
3.4 Global Plasma Derived Medicine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Bleeding Wound
4.1.2 Immunodeficiency
4.1.3 HBV
4.1.4 Tetanus
4.1.5 Rabies
4.1.6 Hemophilia
4.1.7 Others
4.2 Global Plasma Derived Medicine Sales Value by Application
4.2.1 Global Plasma Derived Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Plasma Derived Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Plasma Derived Medicine Sales Value, by Application (%) (2019-2030)
4.3 Global Plasma Derived Medicine Sales Volume by Application
4.3.1 Global Plasma Derived Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Plasma Derived Medicine Sales Volume, by Application (2019-2030)
4.3.3 Global Plasma Derived Medicine Sales Volume, by Application (%) (2019-2030)
4.4 Global Plasma Derived Medicine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Plasma Derived Medicine Sales Value by Region
5.1.1 Global Plasma Derived Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Plasma Derived Medicine Sales Value by Region (2019-2024)
5.1.3 Global Plasma Derived Medicine Sales Value by Region (2025-2030)
5.1.4 Global Plasma Derived Medicine Sales Value by Region (%), (2019-2030)
5.2 Global Plasma Derived Medicine Sales Volume by Region
5.2.1 Global Plasma Derived Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Plasma Derived Medicine Sales Volume by Region (2019-2024)
5.2.3 Global Plasma Derived Medicine Sales Volume by Region (2025-2030)
5.2.4 Global Plasma Derived Medicine Sales Volume by Region (%), (2019-2030)
5.3 Global Plasma Derived Medicine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Plasma Derived Medicine Sales Value, 2019-2030
5.4.2 North America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Plasma Derived Medicine Sales Value, 2019-2030
5.5.2 Europe Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Plasma Derived Medicine Sales Value, 2019-2030
5.6.2 Asia Pacific Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Plasma Derived Medicine Sales Value, 2019-2030
5.7.2 South America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Plasma Derived Medicine Sales Value, 2019-2030
5.8.2 Middle East & Africa Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasma Derived Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Plasma Derived Medicine Sales Value
6.2.1 Key Countries/Regions Plasma Derived Medicine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Plasma Derived Medicine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Plasma Derived Medicine Sales Value, 2019-2030
6.3.2 United States Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Plasma Derived Medicine Sales Value, 2019-2030
6.4.2 Europe Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Plasma Derived Medicine Sales Value, 2019-2030
6.5.2 China Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Plasma Derived Medicine Sales Value, 2019-2030
6.6.2 Japan Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Plasma Derived Medicine Sales Value, 2019-2030
6.7.2 South Korea Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Plasma Derived Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Plasma Derived Medicine Sales Value, 2019-2030
6.9.2 India Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Plasma Derived Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Plasma Derived Medicine Product Offerings
7.1.5 Takeda Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CSL Plasma Derived Medicine Product Offerings
7.2.5 CSL Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Grifols Plasma Derived Medicine Product Offerings
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Octapharma Plasma Derived Medicine Product Offerings
7.4.5 Octapharma Recent Development
7.5 Kedrion
7.5.1 Kedrion Company Information
7.5.2 Kedrion Introduction and Business Overview
7.5.3 Kedrion Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Kedrion Plasma Derived Medicine Product Offerings
7.5.5 Kedrion Recent Development
7.6 LFB Group
7.6.1 LFB Group Company Information
7.6.2 LFB Group Introduction and Business Overview
7.6.3 LFB Group Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 LFB Group Plasma Derived Medicine Product Offerings
7.6.5 LFB Group Recent Development
7.7 Biotest
7.7.1 Biotest Company Information
7.7.2 Biotest Introduction and Business Overview
7.7.3 Biotest Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Biotest Plasma Derived Medicine Product Offerings
7.7.5 Biotest Recent Development
7.8 BPL
7.8.1 BPL Company Information
7.8.2 BPL Introduction and Business Overview
7.8.3 BPL Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 BPL Plasma Derived Medicine Product Offerings
7.8.5 BPL Recent Development
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Information
7.9.2 Shanghai RAAS Introduction and Business Overview
7.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Shanghai RAAS Plasma Derived Medicine Product Offerings
7.9.5 Shanghai RAAS Recent Development
7.10 China Biologic Products
7.10.1 China Biologic Products Company Information
7.10.2 China Biologic Products Introduction and Business Overview
7.10.3 China Biologic Products Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 China Biologic Products Plasma Derived Medicine Product Offerings
7.10.5 China Biologic Products Recent Development
7.11 Hualan Biological Engineering Inc.
7.11.1 Hualan Biological Engineering Inc. Company Information
7.11.2 Hualan Biological Engineering Inc. Introduction and Business Overview
7.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Offerings
7.11.5 Hualan Biological Engineering Inc. Recent Development
7.12 Beijing Tiantan Biological Products Corp
7.12.1 Beijing Tiantan Biological Products Corp Company Information
7.12.2 Beijing Tiantan Biological Products Corp Introduction and Business Overview
7.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Offerings
7.12.5 Beijing Tiantan Biological Products Corp Recent Development
7.13 Pacific Shuanglin
7.13.1 Pacific Shuanglin Company Information
7.13.2 Pacific Shuanglin Introduction and Business Overview
7.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Pacific Shuanglin Plasma Derived Medicine Product Offerings
7.13.5 Pacific Shuanglin Recent Development
7.14 Boya Bio-Pharmaceutical
7.14.1 Boya Bio-Pharmaceutical Company Information
7.14.2 Boya Bio-Pharmaceutical Introduction and Business Overview
7.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Offerings
7.14.5 Boya Bio-Pharmaceutical Recent Development
7.15 Paisi Feike Biology Pharmacy Co., Ltd.
7.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
7.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Introduction and Business Overview
7.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Offerings
7.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
7.16 Xinjiang Deyuan Bioengineering
7.16.1 Xinjiang Deyuan Bioengineering Company Information
7.16.2 Xinjiang Deyuan Bioengineering Introduction and Business Overview
7.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Offerings
7.16.5 Xinjiang Deyuan Bioengineering Recent Development
7.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
7.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
7.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Introduction and Business Overview
7.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Offerings
7.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
7.18 Shenzhen Weiguang
7.18.1 Shenzhen Weiguang Company Information
7.18.2 Shenzhen Weiguang Introduction and Business Overview
7.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Shenzhen Weiguang Plasma Derived Medicine Product Offerings
7.18.5 Shenzhen Weiguang Recent Development
7.19 Shanxi Kangbao
7.19.1 Shanxi Kangbao Company Information
7.19.2 Shanxi Kangbao Introduction and Business Overview
7.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Shanxi Kangbao Plasma Derived Medicine Product Offerings
7.19.5 Shanxi Kangbao Recent Development
7.20 Nanyue Biopharming Corporation Ltd
7.20.1 Nanyue Biopharming Corporation Ltd Company Information
7.20.2 Nanyue Biopharming Corporation Ltd Introduction and Business Overview
7.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Offerings
7.20.5 Nanyue Biopharming Corporation Ltd Recent Development
8 Industry Chain Analysis
8.1 Plasma Derived Medicine Industrial Chain
8.2 Plasma Derived Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasma Derived Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Plasma Derived Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer